• Company
  • Description
  • Recovery Amount
  • Merck (consumer)
  • In re Vytorin/Zetia Marketing, Sales Practices and Products Liability Litigation
  • $41.5 million


District of New Jersey

As consumer subclass counsel and member of the steering committee, G&E attorneys obtained a $41.5 million recovery on behalf of consumers who overpaid for Merck & Co.’s Vytorin and Zetia, which defendants deceptively marketed as being more effective than other anti-cholesterol drugs. This case was brought on behalf of consumers and insurers who bought, used or paid money toward the purchase of these cholesterol drugs, accusing those companies of marketing the drugs in a misleading manner and failing to disclose the results of a negative clinical study in a timely fashion.